{
    "Trade/Device Name(s)": [
        "SAFECARE Multi-Drug Urine Test Dip Card",
        "SAFECARE Multi-Drug Urine Test Cup"
    ],
    "Submitter Information": "Safecare Biotech (Hangzhou) Co. Ltd.",
    "510(k) Number": "K202453",
    "Predicate Device Reference 510(k) Number(s)": [
        "K201120"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NFW",
        "NFY",
        "NGG",
        "NGI",
        "NFV",
        "NGL",
        "PTH",
        "PTG",
        "QAW",
        "QBF",
        "NGM"
    ],
    "Summary Letter Date": "March 24, 2021",
    "Summary Letter Received Date": "August 27, 2020",
    "Submission Date": "August 25, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3640",
        "21 CFR 862.3170",
        "21 CFR 862.3650",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Cocaine and Cocaine Metabolites Test System",
        "Methamphetamine Test System",
        "Morphine Test System",
        "Benzodiazepine Test System",
        "Opiate Test System",
        "Barbiturate Test System",
        "Methadone Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Propoxyphene Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Morphine",
        "Oxycodone",
        "Secobarbital",
        "Buprenorphine",
        "Methylenedioxy-methamphetamine",
        "Phencyclidine",
        "Methadone",
        "Nortriptyline",
        "d-Propoxyphene",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Competitive binding",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for SAFECARE Multi-Drug Urine Test Dip Card and Cup for qualitative detection of multiple drugs in urine using competitive binding lateral flow immunochromatographic assays.",
    "Indications for Use Summary": "Qualitative, simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline, d-Propoxyphene, and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human urine at specified cutoff concentrations; intended for over-the-counter use.",
    "fda_folder": "Toxicology"
}